Related Experiment Video
Updated: May 4, 2026
07:42
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
Published on: November 26, 2015
12.7K
[LncRNA in prostate cancer: an update]
Xiu-Quan Guo1, Tian Lan2, Yang-Min Wang2
1Department of Urology, The Second School of Clinical Medicine, Lanzhou University/Lanzhou General Hospital of Lanzhou Military Region, Lanzhou, Gansu 730050, China. guoxiuquan846@163.com
Zhonghua Nan Ke Xue = National Journal of Andrology
|January 7, 2014
Summary
Long non-coding RNAs (lncRNAs) are crucial in prostate cancer development and spread. Understanding lncRNA roles offers new insights into cancer biology and potential therapeutic targets.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Context:
- The non-protein coding genome, particularly long non-coding RNAs (lncRNAs), plays a significant role in human diseases.
- Prostate cancer biology is increasingly understood to involve complex regulatory mechanisms beyond protein-coding genes.
Purpose:
- This review synthesizes recent research on the function of lncRNAs in prostate cancer.
- To highlight the regulatory roles of lncRNAs in prostate cancer initiation, progression, and metastasis.
Summary:
- Long non-coding RNAs (lncRNAs) are deregulated in prostate cancer.
- Specific lncRNAs function as oncogenes, promoting carcinogenesis and tumor development.
- Altered lncRNA expression levels correlate with cancer recurrence, metastasis, and patient prognosis.
Impact:
- Provides a comprehensive overview of lncRNA involvement in prostate cancer.
- Identifies lncRNAs as potential biomarkers for prostate cancer diagnosis and prognosis.
- Suggests lncRNAs as novel therapeutic targets for prostate cancer treatment.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
03:18Non-LTR Retrotransposons
12.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K